These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35073740)

  • 1. Great Expectations of COVID-19 Herd Immunity.
    Giurgea LT; Morens DM
    mBio; 2022 Feb; 13(1):e0349521. PubMed ID: 35073740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herd Immunity Against Coronavirus: A Review.
    Datta S; Roy A
    Recent Pat Biotechnol; 2022 Aug; 16(3):256-265. PubMed ID: 35400332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2022 Jan; 37(1):13-18. PubMed ID: 34836470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e170122200309. PubMed ID: 35040409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R
    Elsaid M; Nasef MA; Huy NT
    Hum Vaccin Immunother; 2021 Nov; 17(11):3850-3854. PubMed ID: 34612165
    [No Abstract]   [Full Text] [Related]  

  • 10. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide.
    Hussain H; Ganesh A; Milane L; Amiji M
    Expert Opin Drug Deliv; 2023 Apr; 20(4):489-506. PubMed ID: 36890642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Strategy During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2021 Nov; 36(6):316-322. PubMed ID: 34060925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.
    Yadegari I; Omidi M; Smith SR
    Sci Rep; 2021 Nov; 11(1):22970. PubMed ID: 34836984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
    Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
    Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
    Hodgson D; Flasche S; Jit M; Kucharski AJ; ;
    Euro Surveill; 2021 May; 26(20):. PubMed ID: 34018481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.